The latest price target for Geron (NASDAQ:GERN) was reported by Scotiabank on May 8, 2025. The analyst firm set a price target for $1.50 expecting GERN to fall to within 12 months (a possible -3.23% downside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for Geron (NASDAQ:GERN) was provided by Scotiabank, and Geron downgraded their sector perform rating.

The last upgrade for Geron Corp happened on September 12, 2023 when Goldman Sachs raised their price target to $4. Goldman Sachs previously had a neutral for Geron Corp.

The last downgrade for Geron Corp happened on May 8, 2025 when Scotiabank changed their price target from $4 to $1.5 for Geron Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Geron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Geron was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.

While ratings are subjective and will change, the latest Geron (GERN) rating was a downgraded with a price target of $4.00 to $1.50. The current price Geron (GERN) is trading at is $1.55, which is out of the analyst’s predicted range.